Delivery Order 36F79718D0355-36C26024F0071
Award Date
11/3/23
Potential Completion Date
1/31/24
Potential Value
$188K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Alexion Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02210, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Alexion Pharmaceuticals Inc., doing business as Alexion, for the delivery of the drug Strensiq. The award was made by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration and has a ceiling value of $1,253,969.76. The contract is a firm-fixed-price delivery order under the Pharmaceuticals and Drugs GSA Schedule. Alexion has also been awarded a Blanket Purchase Agreement (BPA) by the VA National Acquisition Center for Strensiq, with a...
This is a firm-fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Alexion Pharmaceuticals Inc. under the Pharmaceuticals and Drugs GSA Schedule. The $285,412.29 contract is for the provision of the drug Strensiq to treat perinatal/infantile- and juvenile-onset hypophosphatasia, a rare genetic disorder. Alexion holds a $4,239,517.80 Blanket Purchase Agreement (BPA) with the VA National Acquisition Center for Strensiq, established...
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration to Alexion Pharmaceuticals Inc., a foreign-owned for-profit biopharmaceutical company. The contract is for the supply of the drug Soliris, under Alexion's GSA Schedule contract for Pharmaceuticals and Drugs. The potential value of this specific delivery order is $111,167.52, with a completion date of December 30, 2017. There was no set-aside designation used for this award....
This is a delivery order contract awarded by the Department of Veterans Affairs (VA) to Alexion Pharmaceuticals Inc. for the drug Soliris 300 mg vial. The contract was awarded under the GSA Pharmaceutical and Drugs Federal Supply Schedule (FSS-61-IB), with a firm-fixed-price pricing type. The contract has a ceiling value of $89,993.19 and a period of performance ending on December 31, 2015. Alexion, a global biopharmaceutical company, is the prime contractor and there are no noted...
This is a firm fixed-price delivery order against the Pharmaceuticals and Drugs (FSS-61-IB) schedule contract, awarded by the Department of Veterans Affairs (VA) to Baxalta US Inc., a foreign-owned, for-profit pharmaceutical company. The award, valued at $217,000.00, is for the supply of 1,200 vials of the drug GLASSIA (alpha 1-proteinase inhibitor human, 1 gram/50 milliliters) for the VA's fiscal year 2016 requirements. The contract has a period of performance ending on September 30, 2016 and...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a $17,830.87 delivery order to Genzyme Corporation, Sanofi Genzyme division, for eliglustat for the Puget Sound VA pharmacy. The contract was issued against the Pharmaceuticals and Drugs Federal Supply Schedule, known as FSS-61-IB, with a firm fixed price and completion date of November 1, 2019. The delivery order was not subject to any set-aside designations and will provide the...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a $161,106.60 delivery order contract to Actelion Pharmaceuticals US, Inc., a for-profit manufacturer of pharmaceutical products, to provide the drug Selexipag. This order is placed against Actelion's existing $105 million Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs and a separate $60 million Blanket Purchase Agreement focused on pulmonary arterial hypertension therapies. Actelion...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $74,879.68 firm fixed price delivery order contract to Amylyx Pharmaceuticals Inc., doing business as Amylyx, of Cambridge, Massachusetts. The contract calls for Amylyx to provide sodium phenylbutyrate and taurursodiol powder packets for oral administration to support VHA programs. The place of performance is Amylyx's headquarters in Cambridge. The period of performance is from...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a $154,859.62 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Catalyst Pharmaceuticals, Inc. for the provision of 10mg Firdapse (amifampridine) tablets. The order is for a firm fixed price and has a period of performance through October 31, 2022. The Pharmaceuticals and Drugs schedule, managed by GSA, provides government agencies access to...
The Department of Veterans Affairs Veterans Health Administration awarded a delivery order contract to Ferring Pharmaceuticals Inc., a for-profit manufacturer, to provide the oncology medication Adstiladrin (nadofaragene firadenovec) under the agency's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The $45,829.15 firm-fixed price order is for delivery by December 31, 2024 to support the VA's provision of healthcare services to veterans through its integrated network of...